| Cell line name | CRMi001-A-1 |
|---|---|
| Synonyms | CRMi001-A-1-CLTA-TQ2; NCRM-5-CLTA-TQ2; SANFi002-A-1 |
| Accession | CVCL_UG26 |
| Resource Identification Initiative | To cite this cell line use: CRMi001-A-1 (RRID:CVCL_UG26) |
| Comments | From: NIH Center for Regenerative Medicine (CRM); Bethesda; USA. Characteristics: Using CRISPR/Cas9 CTLA has been endogenously tagged in one allele at the C-terminus with a Tq2-P2A-pac construct. Transfected with: UniProtKB; P42212; GFP (with p.Phe64Leu, p.Tyr66Trp, p.Ser72Ala, p.Asn146Phe, p.His148Asp, p.Met153Thr, p.Val163Ala, p.Ser175Gly, p.Ala206Lys and p.His231Leu = Turquoise2 (Tq2)). Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR). Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168. |
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
| Hierarchy | Parent: CVCL_1E75 (NCRM-5) |
| Sex of cell | Male |
| Age at sampling | <1D |
| Category | Induced pluripotent stem cell |
| Publications | PubMed=30340091; DOI=10.1016/j.scr.2018.10.001 |
| Cross-references | |
| Cell line databases/resources | hPSCreg; CRMi001-A-1 |
| Encyclopedic resources | Wikidata; Q93458788 |
| Entry history | |
| Entry creation | 13-Nov-2018 |
| Last entry update | 29-Jun-2023 |
| Version number | 7 |